Management of inoperable malignant gastric outlet obstructions with WallFlex Duodenal Soft stent: a multicentre prospective study.

Management of inoperable malignant gastric outlet obstructions with WallFlex Duodenal Soft stent: a multicentre prospective study. - Efficacy and Safety of WallFlex Duodenal Soft for GOO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029496

Enrollment

Registered

2017-10-11

Start date

2017-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inoperable malignant gastric outlet obstruction (GOO)

Interventions

WallFlex Duodenal Soft stent is used for patients with symptomatic inoperable malignant GOO

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients aged 20 or older (2) Inoperable malignant gastric outlet obstruction (3) Provision of consent on the use of WallFlex Duodenal Soft stent (4) Provision of informed consent on partcipation to the present study

Exclusion criteria

Exclusion criteria: (1) Contraindicaion for endoscopic procedure (2) Patients who were not considered appropriate participants ot the present study (3) Patients with too tight stricture to bebe traversed by accessory devices.

Design outcomes

Primary

Measure	Time frame
Clinical success: Proportion of patients with 1 point of greater improvement of GOOSS score	—

Secondary

Measure	Time frame
(1) Technical success (2) Stent dysfunction (3) Adverse events (exc. stent dysfunction)	—

Countries

Japan

Contacts

Public ContactHiroaki Shigoka

Toho University Ohashi Medical Center Division of Gastroenterology and Hepatology, Department of Internal Medicine

h-shigoka@oha.toho-u.ac.jp03-3468-1251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026